We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Rigel Pharmaceuticals

News List

Rigel Finalizes Study Design of Fostamatinib Trial for Warm Autoimmune Hemolytic Anemia americanpharmaceuticalreview
December 01, 2020
Rigel Pharmaceuticals has reached agreement with the U.S. Food and Drug Administration (FDA) on the final design of its FORWARD study, a pivotal Phase 3 clinical trial of fostamatinib disodium hexahydrate (fostamatinib) in warm autoimmune hemolytic ...
Rigel Announces New Appointment to Board of Directors americanpharmaceuticalreview
August 28, 2017
Rigel Pharmaceuticals announced that Brian L. Kotzin, M.D. has been appointed to Rigel's board of directors. Kotzin brings to Rigel's board three decades of experience in the areas of immunology and inflammation.